Molecular Data Inc. [NASDAQ: MKD] closed the trading session at $0.94 on 06/08/21. The day’s price range saw the stock hit a low of $0.8028, while the highest price level was $0.9446. The company report on April 1, 2021 that Molecular Data Inc. intends to further upgrade its digital tools using Blockchain.
Molecular Data Inc. (“Molecular Data” or the “Company”) (Nasdaq: MKD), a leading technology-driven platform in China’s chemical industry, announced that it has signed a cooperation agreement with Dalian Lianhua Chemical Co., Ltd. (“Dalian Lianhua”), a leading manufacturer in the subdivision field of boric acid compounds in China. In the future, the two companies will combine the strengths of both parties to help the rapid development of R&D in domestic pharmaceutical companies and the drug synthesis industries.
Molecular Data is already using digital tools including big data and neuron network to achieve the intelligent optimization of the industry supply chain. The selective use of Blockchain including Blockchain Oracle, decentralized oracle network will empower the scientific research progress of domestic pharmaceutical companies.
The stocks have a year to date performance of 11.81 percent and weekly performance of 16.66 percent. The stock has been moved at -7.92 percent over the last six months. The stock has performed 13.16 percent around the most recent 30 days and changed -27.75 percent over the most recent 3-months.
If compared to the average trading volume of 1.46M shares, MKD reached to a volume of 4049514 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Molecular Data Inc. [MKD]:
The Average True Range (ATR) for Molecular Data Inc. is set at 0.06, with the Price to Sales ratio for MKD stock in the period of the last 12 months amounting to 0.11.
MKD stock trade performance evaluation
Molecular Data Inc. [MKD] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 16.66. With this latest performance, MKD shares gained by 13.16% in over the last four-week period, additionally sinking by -7.92% over the last 6 months – not to mention a drop of -52.71% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MKD stock in for the last two-week period is set at 61.01, with the RSI for the last a single of trading hit 70.34, and the three-weeks RSI is set at 54.54 for Molecular Data Inc. [MKD]. The present Moving Average for the last 50 days of trading for this stock 0.8918, while it was recorded at 0.8268 for the last single week of trading, and 1.1153 for the last 200 days.
Molecular Data Inc. [MKD]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Molecular Data Inc. [MKD] shares currently have an operating margin of -4.36 and a Gross Margin at -0.13. Molecular Data Inc.’s Net Margin is presently recorded at -4.32.
Additionally, MKD Total Debt to Total Capital is recorded at 137.48, with Total Debt to Total Assets ending up at 14.96.
Reflecting on the efficiency of the workforce at the company, Molecular Data Inc. [MKD] managed to generate an average of -$251,431 per employee. Receivables Turnover for the company is 49.59 with a Total Asset Turnover recorded at a value of 12.55.Molecular Data Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.00 and a Current Ratio set at 1.00.
Molecular Data Inc. [MKD]: Insider Ownership positions
There are presently around $18 million, or 15.60% of MKD stock, in the hands of institutional investors. The top three institutional holders of MKD stocks are: TB ALTERNATIVE ASSETS LTD. with ownership of 17,646,965, which is approximately 0% of the company’s market cap and around 10.08% of the total institutional ownership; RENAISSANCE TECHNOLOGIES LLC, holding 453,443 shares of the stock with an approximate value of $0.43 million in MKD stocks shares; and CITADEL ADVISORS LLC, currently with $0.26 million in MKD stock with ownership of nearly 478.465% of the company’s market capitalization.
Positions in Molecular Data Inc. stocks held by institutional investors increased at the end of June and at the time of the June reporting period, where 10 institutional holders increased their position in Molecular Data Inc. [NASDAQ:MKD] by around 981,493 shares. Additionally, 2 investors decreased positions by around 9,329,646 shares, while 2 investors held positions by with 8,406,709 shares. The mentioned changes placed institutional holdings at 18,717,848 shares, according to the latest SEC report filing. MKD stock had 7 new institutional investments in for a total of 716,977 shares, while 2 institutional investors sold positions of 9,329,646 shares during the same period.